26 results
Background
Despite the remarkable achievements of the Expanded Programme on Immunization (EPI) in Burkina Faso, numerous challenges remain, including missed opportunities for vaccination (MOV) which...
The BID Learning Network (BLN)/Gavi Data Quality and Use (DQU) Collaborative convened a meeting between July 24-26, 2019 in Lusaka, Zambia. It was attended by 25 participants, including immunization...
In this webinar, the presenter shared lessons learned from Burkina Faso’s experience in improving the quality of immunization and surveillance data for Expanded Program on Immunization (EPI) target...
The BID Learning Network (BLN) invites you to join a webinar entitled “Lessons Learned in Scaling Up: How TDH is Deploying an m-Health Application in 600 Clinics in Burkina Faso.” In 2013, Terre...
Background
Significant progress has been made to increase access to vaccines in Africa since the 1974 launch of the Expanded Programme on Immunization (EPI). Successes include the introduction of...
Background
Despite rapid and tangible progress in vaccine coverage and in premature mortality rates registered in sub-Saharan Africa, inequities to access remain firmly entrenched, large pockets of...
The global recognition of vaccination is strongly related to the fact that it has proved in the past able to dramatically reduce the incidence of certain diseases. Nevertheless, reactions regarding...
The greatest challenge facing expanded programs on immunization in general, and in Burkina Faso in particular, lies in their capacity to achieve and sustain levels of immunization coverage that will...
The Expanded Program on Immunization (EPI) is still in need of improvement. In Burkina Faso in 2003, for example, the Nouna health district had an immunization coverage rate of 31.5%, compared to the...
For over 100 years, large epidemics of meningococcal meningitis have occurred every few years in areas of the African Sahel and sub-Sahel known as the African meningitis belt. Until recently, the...
The optimal long-term vaccination strategies to provide population-level protection against serogroup A Neisseria meningitidis (MenA) are unknown. We developed an age-structured mathematical model of...
The BLN is a platform for peer learning and information exchange intended to enable strong
collaborative links between peers from different countries in support of improved data...
An affordable, highly immunogenic Neisseria meningitidis serogroup A meningococcal conjugate vaccine (PsA—TT) was licensed for use in sub-Saharan Africa in 2009. In 2010, Burkina Faso became the...
A new serogroup A meningococcal conjugate vaccine (PsA-TT, MenAfriVac™) has been developed to combat devastating serogroup A Neisseria meningitis (MenA) epidemics in Africa. A mass immunization...
The impact of a Computerized Immunization Register (CIR) on Expanded Program on Immunization (EPI) with sending SMS to parents before immunization sessions has never been studied in sub-Saharan...
The annual progress report gives a comprehensive overview of the activities and performance of Gavi, the Vaccine Alliance, illustrating the work and achievements of this public-private partnership.
Même si la couverture vaccinale Programme élargi de vaccination (PEV) nationale est élevée au Burkina Faso (95 % d’enfants complètement vaccinés), les mères des enfants suivis par le PEV...
OBJECTIVES: To present first findings of a cost-of-illness (COI) information system implemented in Nouna health district- Burkina Faso. The entire project will include household and provider tangible...
In June 2001, BMGF awarded a grant of US$70 million to create the Meningitis Vaccine Project (MVP) as a partnership between PATH and WHO, with the specific goal of developing an affordable MenA...
The development, through a public–private partnership, of a safe, effective, and affordable vaccine for sub-Saharan Africa, PsA-TT, offers a new paradigm for the development of vaccines...
This report, prepared by the Secretariat for the Decade of Vaccines Global Vaccine Action Plan, serves as the basis for the independent review. As was the case in 2013 and 2014, this report reviews...
This report highlights the achievements made in expanding access to vaccines in Africa and discusses some of the remaining challenges to achieving universal access to vaccines. The timing of this...